drugset / Trial / NCT00373256
A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare treatment with SU011248 plus paclitaxel versus bevacizumab plus paclitaxel to determine which treatment works better against breast cancer
Timeline
- Start
- 2006-11
- Primary completion
- 2009-06
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bevacizumab | Monoclonal antibody | 10 mg/kg | Intravenous |
| Subject | Sunitinib | Small molecule | 37.5 mg | Oral |
| Comparator | Paclitaxel | Small molecule | 90 mg/m2 | Intravenous |